Evidence map›Paper›PMID 16464715›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Shigeki Nagamachi, Seigo Fujita, Ryuichi Nishii, Shigemi Futami, Shozo Tamura, Masanari Mizuta, Masamitsu Nakazato, Takeshi Kurose, Hideyuki Wakamatsu

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Quality and utility of [Annals of nuclear medicine · 2021
    Article
  9. Review
  10. How do we establish cardiac sympathetic nervous system imaging withJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  11. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.European journal of nuclear medicine and molecular imaging · 2019
    Article
  12. Article
  13. Review
  14. Review
  15. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  16. Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  17. Cardiac autonomic imaging with SPECT tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Review
  18. Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
    Article
  19. Cardiovascular imaging in diabetes mellitus.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2011
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shigeki NagamachiDepartment of Radiology, Miyazaki Medical College, Miyazaki, Japan. snagama@med.miyazaki-u.ac.jp
Seigo Fujita
Ryuichi Nishii
Shigemi Futami
Shozo Tamura
Masanari Mizuta
Masamitsu Nakazato
Takeshi Kurose
Hideyuki Wakamatsu
Miyazaki Welfare Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for diagnosing cardiac autonomic neuropathy (CAN) in non-insulin-dependent diabetes mellitus (NIDDM). However, the long-term prognostic value for cardiac events or mortality in NIDDM has not been clarified. METHODS AND

resultsWe investigated the long-term prognostic value of cardiac MIBG imaging for both cardiac event and mortality owing to a variety of causes of death in NIDDM. 144 NIDDM patients were analyzed retrospectively with the end-points of a cardiac event and various causes of mortality. The heart-to-mediastinum uptake ratio on the delayed image (H/M [d]) was obtained from anterior planar imaging. The mean follow-up period was 7.2+/-3.2 years. Seventeen patients had a cardiac event onset and 7 patients died during observation. During the same observation course, 16 patients died, including some who died of cardiac event. Both multivariate and univariate analyses revealed that decreased H/M (d) (<1.7) was the independent predictor of long-term mortality for a variety of causes of death. Although the value of H/M (d) was not a significant prognostic factor for predicting a cardiac event, CAN, diagnosed by a combination of H/M (d) and coefficient variance of RR interval, was an independent predictor for the cardiac event in NIDDM.

conclusionMIBG myocardial scintigraphy was useful for predicting cardiac events and long-term mortality in NIDDM.

Indexed as

3-IodobenzylguanidineAutonomic Nervous System DiseasesComorbidityDiabetes Mellitus, Type 2Diabetic NeuropathiesFemaleHeart DiseasesHumansIncidenceJapanMaleMiddle AgedPrognosisRadionuclide ImagingRadiopharmaceuticalsReproducibility of Results3-IodobenzylguanidineRadiopharmaceuticals

Identifiers

PMID16464715
OpenAlexW2019242378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.